SCHEMBL6600871

SCHEMBL6600871

CCOC(=O)Nc1ccc(CC(=O)N2CCCC(c3ccc(OC)c(OC)c3)=N2)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MAOB P27338 1/20 0.49
PDE4B Q07343 9/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
POLB P06746 1/20 0.42
TP53 P04637 1/20 0.41
KDR P35968 1/20 0.41
EPHX2 P34913 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL143053 0.88 MAOB (0.50) ALDH1A1SMN1; SMN2KDM4EHPGDHSD17B10
SCHEMBL6604710 0.85 LMNA (0.51) ALDH1A1SMN1; SMN2HSD17B10MAOBPDE4B
Hydrochloric Acid SCHEMBL7646587 0.84 LMNA (0.50) ALDH1A1SMN1; SMN2HSD17B10MAOBPDE4B
SCHEMBL145108 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4EHPGDHSD17B10
SCHEMBL6601466 0.84 MAOB (0.56) ALDH1A1SMN1; SMN2HPGDMAOBPDE4B
SCHEMBL6601945 0.82 ABCG2 (0.53) ALDH1A1SMN1; SMN2KDM4EMAOBPDE4B
SCHEMBL12922902 0.82 MET (0.57) ALDH1A1SMN1; SMN2KDM4EHPGDHSD17B10
SCHEMBL144055 0.82 MAOB (0.48) ALDH1A1SMN1; SMN2KDM4EHPGDHSD17B10
SCHEMBL146917 0.82 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KDM4EHPGDHSD17B10
Hydrochloric Acid SCHEMBL7650717 0.81 ABCG2 (0.53) ALDH1A1SMN1; SMN2KDM4EMAOBPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed